You searched for "treatment"
Update on immunotherapy for non-muscle invasive transitional cell carcinoma of the bladder
Patients with high-risk non-muscle invasive bladder cancer (NMIBC) that have failed Bacillus Calmette-Guérin (BCG) treatment are a difficult group to treat, and many may not be suitable for the preferred treatment option of radical cystectomy. Bladder-preserving treatments for BCG-unresponsive high-risk...Focal therapy trials
Men with localised prostate cancer have traditionally required whole gland treatment involving radical prostatectomy or radical radiation treatment, independent of disease location and size. Increasing evidence supports the use of active treatment only in those men diagnosed with prostate cancer...
Scientific Advances in Reconstructive Urology and Tissue Engineering
Scientific Advances in Reconstructive Urology and Tissue Engineering stands as a beacon in the field, providing a comprehensive exploration of cutting-edge developments in the intersection of reconstructive urology and tissue engineering. Edited by Matthias D Hofer, this paperback edition comprises...
Prostatic artery embolisation versus sham
Randomised trials with use of sham is uncommon in the surgical literature, which makes this paper more interesting. Many different treatments are available for treating lower urinary tract symptoms / benign prostatic hyperplasia (LUTS / BPH). Prostatic artery embolisation (PAE)...Urinary incontinence in women – part 2: management
In the second part of our comprehensive overview of urinary incontinence (UI) the authors explore the plethora of treatment options for this complex condition. (Part 1 available here). Conservative management Initial treatment of incontinence should be conservative. Caffeine reduction and...
Transurethral en bloc resection versus standard resection of bladder tumour
Bladder cancer is a common urological malignancy, with around 610,000 new cases and 220,000 deaths worldwide in 2022. Approximately 75% of these cases are non-muscle-invasive bladder cancer (NMIBC). The conventional method for treating NMIBC is standard resection (SR), performed transurethrally,...The Urology Foundation
The Urology Foundation (TUF) is the only charity in the United Kingdom that raises money for research into all types of urological disease. Our ultimate aim as a charity is to discover the causes of urology cancers and conditions, to...Redundant! Do urological surgeons have a future in treating urological cancers? RSM Urology Section Meeting
December 2023 marked the latest RSM Urology Section event. Alongside the Winter Short Papers Prize presentations, the theme of the day was major urological cancers and the role of the urologist in patient management within the multidisciplinary team (MDT). We...TechRing transforms men's sexual health management
In the realm of urology, the diagnosis and treatment of erectile dysfunction (ED) have long relied on subjective assessments, which can lead to mismanagement of patient care. FirmTech's innovative device, the TechRing, aims to revolutionise this practice by providing urologists...Benign prostatic hyperplasia: what are the benefits and harms of various surgical management options?
Benign prostatic hyperplasia (BPH) is characterised by stromal and epithelial prostatic cell hyperplasia. The enlarged prostate may be associated with voiding and storage lower urinary tract symptoms (LUTS). These have been predominantly attributed to bladder outlet obstruction (BOO), assumed to...
Reliability of grading of VUR and other findings on VCUG
The gold standard for diagnosing VUR is still the voiding cycstogram (VCUG). These authors looked at the inter observer variability of grading of vesicoureteral reflux (VUR) using a VCUG and highlight the implications for treatment and prognosis as a results....
